Objective To determine the associations between age at first postnatal corticosteroids (PNS)
exposure and risk for severe bronchopulmonary dysplasia (BPD) and neurodevelopmental …

Objective To determine the association of timing of steroid therapy for bronchopulmonary
dysplasia (BPD) and outcomes. Methods Retrospective cohort study of preterm infants …

OBJECTIVE. Postnatal steroid use decreases lung inflammation but increases impairment.
We hypothesized that increased dose is associated with increased neurodevelopmental …

Although antenatal steroids reduce risk factors for bronchopulmonary dysplasia (BPD) in
preterm infants, their effect on BPD is conflicting. We hypothesised that the lack of protective …

Objective: To study the association between reduced use of postnatal steroids for
bronchopulmonary dysplasia (BPD) in very low birthweight (VLBW) infants and oxygen (O2) …

Objectives: To compare death and/or neurodevelopmental outcomes of preterm infants
exposed to inhaled and/or systemic steroids with those without exposure, and examine the …

BACKGROUND. Postnatal corticosteroids were widely used in the 1990s in an attempt to
reduce the incidence of bronchopulmonary dysplasia. However, high rates of short-term …

Aim: To study prevalence and predictive factors of bronchopulmonary dysplasia (BPD) in a
cohort of preterm infants with a high incidence of prenatal steroid and surfactant treatment …

Background Recent reports have raised concerns that postnatal steroids may cause neuro-
developmental impairment in preterm infants. This systematic review was performed with the …

Are postnatal steroids ever justified to treat severe bronchopulmonary dysplasia? | ADC Fetal &
Neonatal Edition Skip to main content Viewing from: Google Indexer BMJ Journals Subscribe …